Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Second approval for CEA-Scan

Oct. 11, 1996

Diatide begins phase II trial of imaging agent for locating infections

Oct. 11, 1996

Gensia to file NDA amendment for GenESA System

Oct. 11, 1996

American Biogenetic Sciences and Gull form joint venture

Oct. 11, 1996

Introduction of integrated test for breast and ovarian cancer ahead of schedule

Oct. 4, 1996

Antex awarded SBIR grant for diagnostic tests

Oct. 4, 1996

Broad patent coverage for Sonus's ultrasound contrast agents

Oct. 4, 1996

Promising clinical results with gastrointestinal cancer diagnostic

Oct. 4, 1996

Japanese licensing agreement for Geron's telomerase detection technology

Oct. 4, 1996

Albunex dispute settled

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.